• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Big setback for Lilly

anonymous

Guest
Verzenio fails and Levi Garraway says the outcome is unfortunate.
bc0dcf86